|
WINNIPEG, MANITOBA--(Marketwired - Sept. 20, 2013) - Miraculins Inc. (TSX VENTURE:MOM), (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, is pleased to announce the first close of a private placement offering (the "Offering") with aggregate gross proceeds to the Company of $430,000 from the sale of 7,166,667 units ("Units") at a price of $0.06 per Unit. Each Unit is comprised of one common share of the Company (a "Share") and one half of one Share purchase warrant (a "Warrant"). |
